The Rainbow Cohort: saquinavir/r is effective and well tolerated in antiretroviral therapy (ART)-naïve patients – 48-week results from Germany

  • Poster presentation: Purpose of the study The aim of the Rainbow Cohort is to assess the tolerability and efficacy of initiating treatment with, or switching treatment to saquinavir (SQV) 500 mg film-coated tablet formulation. We present the final 48-week subgroup analysis of antiretroviral therapy (ART)-naïve patients. ...

Download full text files

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Heribert Knechten, Christoph Stephan, Thomas Lutz, Albrecht Stoehr, Andreas Carganico, Gaby Knecht, Carl Knud Schewe, Hans Jaeger, Christoph Mayr, Franz Mosthaf, Eva Wolf, Egbert Wellmann, Andre Tappe
URN:urn:nbn:de:hebis:30-70650
DOI:https://doi.org/10.1186/1758-2652-11-S1-P13
Parent Title (English):Journal of the International AIDS Society
Publisher:Springer
Place of publication:Berlin ; Heidelberg
Document Type:Article
Language:English
Date of Publication (online):2009/09/20
Date of first Publication:2008/11/10
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Contributing Corporation:Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 9–13 November 2008
Release Date:2009/09/20
Volume:11(Suppl 1)
Issue:P13
Page Number:2
First Page:1
Last Page:2
Note:
© 2008 Knechten et al; licensee BioMed Central Ltd.
Source:Journal of the International AIDS Society 2008, 11(Suppl 1):P13 ; doi:10.1186/1758-2652-11-S1-P13 ; from Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 9–13 November 2008
HeBIS-PPN:218728247
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Licence (German):License LogoDeutsches Urheberrecht